Praxis Precision Medicines, Inc.
ulixacaltamide HCl
essential tremor in adults
Countdown
206days
FDA decision · Jan 29, 2027
What's at stake
The FDA's approval decision on ulixacaltamide HCl for essential tremor in adults is due Jan 29, 2027. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 14h ago
“The FDA has set a target action date under the Prescription Drug User Fee Act of January 29, 2027”